AL
ENTA icon

AJO LP’s Enanta Pharmaceuticals ENTA Stock Holding History

AJO LP’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-43,723
Closed -$2M – 387
2020
Q3 		$2M Buy
43,723
+11,108
+34% +$538K 0.02% 386
2020
Q2 		$1.64M Buy
32,615
+11,586
+55% +$600K 0.02% 411
2020
Q1 		$1.08M Sell
21,029
-82,425
-80% -$4.39M 0.01% 417
2019
Q4 		$6.39M Buy
103,454
+32,686
+46% +$2.03M 0.04% 267
2019
Q3 		$4.25M Buy
70,768
+66,673
+1,628% +$4.95M 0.02% 321
2019
Q2 		$346K Buy
+4,095
New +$368K ﹤0.01% 555
2018
Q4 		– Sell
-73,166
Closed -$6.25M – 655
2018
Q3 		$6.25M Sell
73,166
-6,281
-8% -$629K 0.03% 311
2018
Q2 		$9.21M Sell
79,447
-22,157
-22% -$2.21M 0.04% 252
2018
Q1 		$8.22M Buy
101,604
+2,056
+2% +$158K 0.04% 251
2017
Q4 		$5.84M Buy
99,548
+67,381
+209% +$3.37M 0.03% 306
2017
Q3 		$1.5M Buy
+32,167
New +$1.29M 0.01% 450
2017
Q1 		– Sell
-200,422
Closed -$6.71M – 543
2016
Q4 		$6.71M Sell
200,422
-205,843
-51% -$5.9M 0.03% 249
2016
Q3 		$10.8M Buy
406,265
+347,622
+593% +$8.07M 0.05% 210
2016
Q2 		$1.29M Sell
58,643
-29,073
-33% -$761K 0.01% 375
2016
Q1 		$2.58M Buy
+87,716
New +$2.44M 0.01% 321
2015
Q4 		– Sell
-19,778
Closed -$715K – 528
2015
Q3 		$715K Sell
19,778
-66,282
-77% -$2.85M ﹤0.01% 432
2015
Q2 		$3.87M Buy
+86,060
New +$3.35M 0.02% 332

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AJO LP's ENTA Position: Q4 2020 in Review

AJO LP sold out of Enanta Pharmaceuticals (ENTA) in Q4 2020, closing a stake of 43,723 shares — an estimated $2M sold.

AJO LP first reported a position in ENTA in Q2 2015 and held it in 17 quarters. The position peaked at $10.8M in Q3 2016. 151 funds tracked by Wall St. Rank hold ENTA as of Q4 2020.

  • AJO LP reported no remaining Enanta Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 43,723 Enanta Pharmaceuticals shares in Q4 2020, an estimated $2M.
  • AJO LP first reported a position in Enanta Pharmaceuticals in Q2 2015 and held it in 17 quarters.
  • AJO LP's Enanta Pharmaceuticals position peaked at $10.8M in Q3 2016.
  • 151 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.